Literature DB >> 20425496

Neuregulin signaling and heart failure.

Zhenggang Jiang1, Mingdong Zhou.   

Abstract

Neuregulin-1 (NRG-1), a ligand of receptor tyrosine kinases of the ErbB family, plays a critical role in cardiovascular development and maintenance of adult heart function. Results from cellular, animal, and clinical experiments have shown NRG-1 to be a promising drug candidate for restoring cardiac function after cardiac injury. Various mechanisms have been suggested to be involved in this process, such as improving sarcomeric structure or cell-cell adhesion, promoting proliferation and survival of cardiac myocytes, balancing Ca(2+) homeostasis, modulating inotropic effects, promoting angiogenesis, and preventing atherosclerosis. However, the contribution of these effects to the restoration of cardiac function remains to be estimated, and it may depend on the specific events that led to heart failure. Meanwhile, distinct and crossed signaling pathways downstream of NRG-1 may play a role in these underlying mechanisms, resulting in a complicated network of signaling mediating the function of NRG-1.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20425496     DOI: 10.1007/s11897-010-0003-y

Source DB:  PubMed          Journal:  Curr Heart Fail Rep        ISSN: 1546-9530


  49 in total

1.  Heregulin, cysteine rich-61 and matrix metalloproteinase 9 expression in human carotid atherosclerotic plaques: relationship with clinical data.

Authors:  F Sigala; S Georgopoulos; E Papalambros; D Chasiotis; G Vourliotakis; A Niforou; A Kotsinas; N Kavantzas; E Patsouris; V G Gorgoulis; E Bastounis
Journal:  Eur J Vasc Endovasc Surg       Date:  2006-06-13       Impact factor: 7.069

2.  Abnormal intrastore calcium signaling in chronic heart failure.

Authors:  Zuzana Kubalova; Dmitry Terentyev; Serge Viatchenko-Karpinski; Yoshinori Nishijima; Inna Györke; Radmila Terentyeva; Daise N Q da Cuñha; Arun Sridhar; David S Feldman; Robert L Hamlin; Cynthia A Carnes; Sandor Györke
Journal:  Proc Natl Acad Sci U S A       Date:  2005-09-19       Impact factor: 11.205

3.  Focal adhesion kinase and p130Cas mediate both sarcomeric organization and activation of genes associated with cardiac myocyte hypertrophy.

Authors:  B Kovacic-Milivojević; F Roediger; E A Almeida; C H Damsky; D G Gardner; D Ilić
Journal:  Mol Biol Cell       Date:  2001-08       Impact factor: 4.138

4.  Abnormal Ca2+ release, but normal ryanodine receptors, in canine and human heart failure.

Authors:  Ming Tao Jiang; Andrew J Lokuta; Emily F Farrell; Matthew R Wolff; Robert A Haworth; Héctor H Valdivia
Journal:  Circ Res       Date:  2002-11-29       Impact factor: 17.367

Review 5.  Cardiotoxicity in signal transduction therapeutics: erbB2 antibodies and the heart.

Authors:  J W Schneider; A Y Chang; T P Rocco
Journal:  Semin Oncol       Date:  2001-10       Impact factor: 4.929

6.  Neuregulin-1 promotes cardiomyocyte differentiation of genetically engineered embryonic stem cell clones.

Authors:  Zhi Wang; Guotong Xu; Yalan Wu; Shaowen Liu; Baogui Sun; Qiuyan Dai
Journal:  BMB Rep       Date:  2008-10-31       Impact factor: 4.778

7.  Identification of the major protein phosphatases in mammalian cardiac muscle which dephosphorylate phospholamban.

Authors:  L K MacDougall; L R Jones; P Cohen
Journal:  Eur J Biochem       Date:  1991-03-28

8.  Cardiac developmental defects and eccentric right ventricular hypertrophy in cardiomyocyte focal adhesion kinase (FAK) conditional knockout mice.

Authors:  Xu Peng; Xiaoyang Wu; Joseph E Druso; Huijun Wei; Ann Yong-Jin Park; Marc S Kraus; Ana Alcaraz; Ju Chen; Shu Chien; Richard A Cerione; Jun-Lin Guan
Journal:  Proc Natl Acad Sci U S A       Date:  2008-04-30       Impact factor: 11.205

9.  Neuregulins regulate cardiac parasympathetic activity: muscarinic modulation of beta-adrenergic activity in myocytes from mice with neuregulin-1 gene deletion.

Authors:  Katashi Okoshi; Masaharu Nakayama; Xinhua Yan; Marina P Okoshi; Adam J T Schuldt; Mark A Marchionni; Beverly H Lorell
Journal:  Circulation       Date:  2004-08-02       Impact factor: 29.690

10.  Evidence for protein phosphatase inhibitor-1 playing an amplifier role in beta-adrenergic signaling in cardiac myocytes.

Authors:  Ali El-Armouche; Thomas Rau; Oliver Zolk; Diana Ditz; Torsten Pamminger; Wolfram-H Zimmermann; Elmar Jäckel; Sian E Harding; Peter Boknik; Joachim Neumann; Thomas Eschenhagen
Journal:  FASEB J       Date:  2003-01-02       Impact factor: 5.191

View more
  12 in total

1.  Trastuzumab-induced cardiac dysfunction: A 'dual-hit'.

Authors:  Matthew Zeglinski; Ana Ludke; Davinder S Jassal; Pawan K Singal
Journal:  Exp Clin Cardiol       Date:  2011

Review 2.  Novel biomarkers in chronic heart failure.

Authors:  Tariq Ahmad; Mona Fiuzat; G Michael Felker; Christopher O'Connor
Journal:  Nat Rev Cardiol       Date:  2012-03-27       Impact factor: 32.419

3.  The ShcA phosphotyrosine docking protein uses distinct mechanisms to regulate myocyte and global heart function.

Authors:  Rachel D Vanderlaan; W Rod Hardy; M Golam Kabir; Adrian Pasculescu; Nina Jones; Pieter P deTombe; Peter H Backx; Tony Pawson
Journal:  Circ Res       Date:  2010-12-09       Impact factor: 17.367

4.  The Src homology and collagen A (ShcA) adaptor protein is required for the spatial organization of the costamere/Z-disk network during heart development.

Authors:  Mohamed Mlih; Lionel Host; Sophie Martin; Nathalie Niederhoffer; Laurent Monassier; Jérôme Terrand; Nadia Messaddeq; Michael Radke; Michael Gotthardt; Véronique Bruban; Frank Kober; Monique Bernard; Emmanuelle Canet-Soulas; Francisco Abt-Jijon; Philippe Boucher; Rachel L Matz
Journal:  J Biol Chem       Date:  2014-12-08       Impact factor: 5.157

5.  Implications of Autophagy and Oxidative Stress in Trastuzumab-Mediated Cardiac Toxicities.

Authors:  N Mohan; J Jiang; W J Wu
Journal:  Austin Pharmacol Pharm       Date:  2017-08-15

Review 6.  The Molecular Mechanisms of Cardiotoxicity Induced by HER2, VEGF, and Tyrosine Kinase Inhibitors: an Updated Review.

Authors:  Qinchao Wu; Baochen Bai; Chao Tian; Daisong Li; Haichu Yu; Bingxue Song; Bing Li; Xianming Chu
Journal:  Cardiovasc Drugs Ther       Date:  2021-04-13       Impact factor: 3.727

Review 7.  The roles of neuregulin-1 in cardiac development, homeostasis, and disease.

Authors:  Cassady E Rupert; Kareen Lk Coulombe
Journal:  Biomark Insights       Date:  2015-04-08

8.  The HER2 Receptor in Breast Cancer: Pathophysiology, Clinical Use, and New Advances in Therapy.

Authors:  Zahi Mitri; Tina Constantine; Ruth O'Regan
Journal:  Chemother Res Pract       Date:  2012-12-20

9.  Gene transfer of human neuregulin-1 attenuates ventricular remodeling in diabetic cardiomyopathy rats.

Authors:  Bingong Li; Jian Xiao; Yong Li; Jian Zhang; Minghui Zeng
Journal:  Exp Ther Med       Date:  2013-08-27       Impact factor: 2.447

10.  Trastuzumab and target-therapy side effects: Is still valid to differentiate anthracycline Type I from Type II cardiomyopathies?

Authors:  Gennaro Riccio; Carmela Coppola; Giovanna Piscopo; Immacolata Capasso; Carlo Maurea; Emanuela Esposito; Claudia De Lorenzo; Nicola Maurea
Journal:  Hum Vaccin Immunother       Date:  2016-02-02       Impact factor: 3.452

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.